新闻

 

Capnia names chairman, CEO

Palo Alto, CA - August 6, 2007 - Capnia Inc. named Ernest Mario chairman and chief executive officer Monday.

Palo Alto-based Capnia said Mario joins the company from Liberty Corner, N.J.-based Reliant Pharmaceuticals Inc., where he served in the same roles, and has 40 years of experience in the pharmaceutical industry.

He is an adjunct professor of pharmacy at the University of Rhode Island and a partner with Pappas Ventures, a North Carolina-based life sciences venture capital firm.

Capnia is a privately-held drug development company focused on treatments for migraine, rhinitis and other conditions. The company is backed by Vivo Ventures and Asset Management Partners, both of Palo Alto; TeknoInvest and Alliance Venture, both of Oslo, Norway; and San Francisco-based Sagamore Bioventures.

« 回 新闻

关于我们

维梧生技创业投资管理公司( Vivo Ventures)成立于1996年, 是一家专注于于生命科学领域的风险投资公司。 管理着超过六亿五千美金的维梧生技正通过旗下第六个基金对北美、亚洲,特别是大中华市场,极具潜力的生物科技、生命科学,制药,器械,及医疗健康服务公司进行投资。 与其他最近才开始关注中国市场的投资公司相比,我们对大中华地区有深层次的了解 更多